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Introduction
RP technologies are gaining importance as fabrication tech-
niques for preparation of 3D scaffolds used in various tissue 
engineering applications. The possibility to design and customise 
scaffold architecture and hence properties with a high degree of 
reproducibility has made RP a promising alternative to classi-
cal scaffolding technologies. Different RP techniques like fused 
deposition modeling,1 selective laser sintering2 and stereolithog-
raphy3 have successfully been used for the fabrication of scaf-
folds for bone tissue engineering. RP scaffolds can be prepared 
from different materials like polymers, metals and composites.1,4,5 
Using Computer Aided Design/Computer Aided Manufacturing 
(CAD/CAM) softwares, the mechanical properties6 and pore 
sizes7 can be controlled. It is also possible to fabricate anatomi-
cal shapes8 by combining and integrating RP techniques with 
imaging techniques like CT scans, thus offering patient specific 
solutions.
While RP techniques can be used to create 3D scaffolds with 
sufficient mechanical strength by controlling overall geometri-
cal design and porosity, they do not yet possess the resolution to 
fabricate nano- and sub-micrometer structures that can mimic 
Combining technologies to engineer scaffolds that can offer physical and chemical cues to cells is an attractive approach 
in tissue engineering and regenerative medicine. In this study, we have fabricated polymer-ceramic hybrid scaffolds for 
bone regeneration by combining rapid prototyping (Rp), electrospinning (eSp) and a biomimetic coating method in 
order to provide mechanical support and a physico-chemical environment mimicking both the organic and inorganic 
phases of bone extracellular matrix (eCM). poly(ethylene oxide terephthalate)-poly(buthylene terephthalate) (peot/pBt) 
block copolymer was used to produce three dimensional scaffolds by combining 3D fiber (3DF) deposition, and eSp, 
and these constructs were then coated with a Ca-p layer in a simulated physiological solution. Scaffold morphology and 
composition were studied using scanning electron microscopy (SeM) coupled to energy dispersive X-ray analyzer (eDX) 
and Fourier tranform Infrared Spectroscopy (FtIR). Bone marrow derived human mesenchymal stromal cells (hMSCs) 
were cultured on coated and uncoated 3DF and 3DF + eSp scaffolds for up to 21 d in basic and mineralization medium 
and cell attachment, proliferation, and expression of genes related to osteogenesis were assessed. Cells attached, 
proliferated and secreted eCM on all the scaffolds. there were no significant differences in metabolic activity among the 
different groups on days 7 and 21. Coated 3DF scaffolds showed a significantly higher DNA amount in basic medium at 21 
d compared with the coated 3DF + eSp scaffolds, whereas in mineralization medium, the presence of coating in 3DF+eSp 
scaffolds led to a significant decrease in the amount of DNA. An effect of combining different scaffolding technologies 
and material types on expression of a number of osteogenic markers (cbfa1, BMp-2, op, oC and oN) was observed, 
suggesting the potential use of this approach in bone tissue engineering.
Combining technologies to create bioactive 
hybrid scaffolds for bone tissue engineering
Anandkumar Nandakumar, Ana Barradas, Jan de Boer, Lorenzo Moroni, Clemens van Blitterswijk and pamela Habibovic*
Department of tissue Regeneration; MIRA Institute for Biomedical technology and technical Medicine; University of twente; enschede, the Netherlands
Keywords: rapid prototyping, electrospinning, biomimetic coating, polymer, calcium-phosphate, bone tissue engineering
the ECM of a cell. In this regard, ESP is gaining widespread 
attention. The possibility of creating an ECM-like milieu for 
cells to attach, grow and proliferate has been the main advantage 
of this method. High voltage is applied to a polymer solution or 
a melt to produce non-woven fiber meshes in the nanometres to 
micrometres range that have been used as scaffolds and delivery 
vehicles.9-14 The diameter and morphology of the mesh is influ-
enced by the polymer-solvent system, concentration, flow, col-
lector distance, voltage and ambient conditions like temperature 
and humidity.15-18
In few studies, structurally hierarchical scaffolds (macro to 
nano level) for bone19 and cartilage20 tissue engineering applica-
tions have been fabricated. Such an approach ensures that a stable 
support structure is available through the RP compartment of 
the construct while the ECM-like mesh produced by ESP pro-
vides physical cues for the cells. The electrospun layer can also act 
as a sieve and entrap cells inside the scaffold thereby increasing 
seeding efficiency. On the other hand, presence of such a mesh 
should not compromise supply of nutrients into the scaffold and 
ingrowth of blood vessels.
Scaffolds for load-bearing applications in bone regeneration 
should be mechanically stable to provide mechanical support, as 
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used sodium silicate as a nucleating agent and deposited a bio-
mimetic apatite coating on starch-polycaprolactone (PCL) based 
3D scaffolds using static and dynamic conditions. Arafat et al.32 
deposited a CA coating in combination with gelatin on PCL/
tricalcium phosphate (TCP) 3D scaffolds prepared by a screw 
extrusion system.
In order to create scaffolds that encompass the required phys-
ical and chemical cues for bone tissue engineering applications, 
in the present study, we combined different technologies, each 
of which should add a new dimension to the resulting scaffolds. 
To this end, we used 3DF to create a mechanically stable struc-
ture, ESP to provide a random mesh mimicking the ECM and 
a Ca-P coating to increase bioactivity of polymer used to build 
the scaffolds. We used a PEOT/PBT block copolymer, com-
mercially sold under the name Polyactive™ (PA), with tunable 
properties that has been used for various bone,33 cartilage34 and 
osteo-chondral35 tissue engineering applications before. The bio-
logical performance of the hybrid scaffolds developed here was 
evaluated in vitro by culturing hMSCs and analyzing attach-
ment, metabolic activity and gene expression levels for osteo-
genic markers.
Results
Fabrication and characterization of scaffolds. A schematic 
of the fabrication methodology used to produce coated and 
uncoated 3DF and 3DF + ESP scaffolds is shown in Figure 1. 
Fiber diameter of the scaffolds was 249 ± 21 μm. Fiber spac-
ing and layer thickness were 830 ± 40 μm and 246 ± 22 μm, 
respectively and these values are in close agreement with the 
input settings during fabrication. Electrospun meshes consisted 
well as bioactive, facilitating or initiating proliferation and osteo-
genic differentiation of cells, ECM production and eventually 
bone deposition. As the inorganic component of bone is primar-
ily composed of calcium-phosphate (Ca-P) in the form of biologi-
cal apatite, incorporation of Ca-P is another key aspect of scaffold 
fabrication for bone tissue engineering applications. Ca-P can be 
added to the bulk material to prepare composite scaffolds or it 
can be applied as a surface coating. Plasma spraying is the tra-
ditional coating method for coating hip implants with hydroxy-
apatite.21 Although excellent clinical results were obtained,22 the 
process has limitations. The extremely high temperature makes 
it impossible to coat thermally unstable substrates like polymers 
or to incorporate biologically active molecules.23 Plasma spraying 
only allows for the coating of thermodynamically stable phases 
and biologically relevant phases like octacalcium phosphate 
(OCP)24 and carbonated apatite (CA)25 cannot be coated by 
this method. This line-of-sight technique also poses limitations 
while coating implants or substrates with complex geometrical 
shapes.26 Research has led to the development of several other 
Ca-P coating processes to overcome the limitations of plasma 
spraying. Among them, biomimetic coating methods involving 
the immersion of the substrate into solutions simulating physio-
logical fluids are very attractive as the process takes place at near-
physiological pH and temperatures, allowing coating of complex 
and thermally unstable substrates and the incorporation of pro-
teins and growth factors.27,28 Kokubo et al.29 developed simulated 
body fluid (SBF), a solution resembling human blood plasma, in 
order to study the ability of biomaterials to mineralise in vitro. 
Based on this, Barrere et al.30 developed a two-step procedure 
using a supersaturated solution of SBF (SBF × 5) to coat biomate-
rial surfaces with a Ca-P layer. Recently, Oliviera and coworkers31 
Figure 1. A schematic illustration of the different technologies involved in fabricating the hybrid scaffolds used in this study. (A) 3-D fiber deposition 
(3DF) enables a controlled layer by layer deposition of extruded polymer, (B) electrospinning to produce extra-cellular matrix like fibers and (C) Biomi-
metic calcium phosphate coating to enhance osteoconductivity of the scaffolds.
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amounts among different scaffold types. When coated scaffolds 
were compared in basic medium, the presence of electrospun 
fibers reduced the amount of DNA significantly (3DF + ESP + 
coating < 3DF + coating). In mineralization medium, 3DF + 
ESP scaffolds had significantly higher DNA amounts compared 
with coated scaffolds of the same type.
Cell morphology using SEM. Figure 6 shows SEM images of 
cell-scaffold constructs cultured in basic medium at 21 d. From the 
images, it can be observed that cells penetrated into the scaffolds. 
The retention of cells by the electrospun mesh and the preferential 
attachment of cells to the fibers compared with the struts of the 
3D scaffold can be seen in Figure 6C. An open ESP + 3DF scaf-
fold is shown in the inset in C and a cell layer covering the electro-
spun mesh can be observed. The white arrow points to electrospun 
fibers. Figures 6A and F show the attachment of hMSCs on Ca-P 
coatings and on electrospun fibers respectively with arrows point-
ing to calcium phosphate particles and electrospun fibers.
Gene expression analysis using quantitative PCR. The 
expression of Osteocalcin (OC), Bone Sialoprotein (BSP), Runt-
related Transcription Factor-2 (RUNX2/cbfa-1), Collagen type 
1 (Col-I), Osteopontin (OP), Osteonectin (ON), and Alkaline 
Phosphatase (ALP) as markers of osteogenic differentiation was 
analyzed on days 7 (Fig. 7) and 21 (Fig. 8) to evaluate the osteo-
genic potential of the different scaffolds. The fold induction was 
calculated relative to the expression of the genes on the 3DF scaf-
fold in basic medium. The effect of Ca-P coating and electrospun 
fibers in each medium was analyzed.
Effect of Ca-P coating. On day 7, significant upregulation of 
BMP-2 expression was observed in both coated scaffolds in basic 
medium. A trend showing upregulation of OP in presence of 
Ca-P coating was observed in both media, and this upregulation 
was significant in the 3DF+ESP scaffold group in basic medium. 
In mineralization medium, the Ca-P coating significantly down-
regulated the expression of ALP, BSP and OC in 3DF coated 
scaffolds, while 3DF+ESP coated scaffolds in basic medium had 
of fibers with a diameter of 5.1 ± 0.94 μm. Figure 2A shows a 
3DF scaffold while 2B shows an “open” 3DF + ESP scaffold 
to visualize the concept of combining the two technologies. 
3DF and 3DF + ESP scaffolds were coated with Ca-P under 
near-physiological conditions. The SEM images showing the 
morphology of the coating, EDX spectrum and mapping for 
calcium and phosphorus and the FTIR spectrum are presented 
in Figure 3. The SEM images along with the EDX mapping 
show that the coating homogenously covered the surface of the 
3DF scaffolds (Fig. 3A–D). Figure 3E shows a homogenous 
distribution of the Ca-P coating on electrospun fibers of the 
scaffold. The coating consisted of plate-like crystals, with a size 
of 1–2 μm, orientation of which was perpendicular to the sur-
face of the fibers (Fig. 3F). FTIR spectrum of the Ca-P coat-
ing indicated mainly the OCP phase. In addition, the spectrum 
showed incorporation of carbonate into the coating. Typical 
P-O bands were observed at 562.5 and 602 cm-1. In an ear-
lier study by Du et al.36 on similar calcium phosphate coatings 
deposited on PA the bands at 1,104, 1,041 and 960 cm-1 were 
assigned to P-O stretching in PO
4
 and HPO
4
 group. In the cur-
rent spectrum, the 1,104 and 1,041 appear to have shifted to 
1,114 and 1,040 cm-1 while the 960 cm-1 band was consistent. 
Du. et al. also identified carbonate incorporation by bands at 
1,467, 1,454, 1,413 and 873 cm-1 whereas in the current study, 
carbonate bands were observed at 1,420, 1,468 and 870 cm-1.
Metabolism and cell numbers. Alamar Blue assay was used 
to determine the metabolic activity of cells seeded on the differ-
ent scaffolds. As seen in Figure 4, no significant differences were 
observed between cells seeded on different scaffolds and in dif-
ferent media over time.
On day 21, the amount of DNA present in the scaffolds was 
analyzed (Fig. 5). No significant differences due to the culture 
media were observed. However the presence of electrospun fibers 
and coatings had a significant effect on the amount of DNA. 
In both media, 3DF + ESP + coating showed the lowest DNA 
Figure 2. Scaffold morphology using SeM (A) 3DF scaffold prepared by rapid prototyping. (B) 3DF + eSp scaffold prepared by combining rapid proto-
typing and electrospinning. the scaffold has been “opened” to enable visualization of the electrospun fiber meshes. Scale bar = 500 μm.
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Figure 3. Calcium-phosphate coated rapid prototyped scaffolds. Morphology and characterization. (A) SeM image of a 3DF scaffold coated with calcium-
phosphate (scale bar = 200 μm). (B) eDX spectrum of the scaffold showing Ca and p peaks, (C and D) eDX elemental mapping of calcium and phosphorus 
respectively, (E) electrospun fibers from a 3DF + eSp scaffold that have been coated with calcium-phosphate (scale bar = 100 μm). (F) High magnification 
SeM image showing the morphology of crystals formed during coating (scale bar = 10 μm), (G) Ft-IR spectrum of calcium-phosphate coating.
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serve to mimic the fibrillar nature of ECM and they generally 
provide a suitable surface for cell attachment. The combination 
of 3DF and ESP has already shown enhanced cellular response 
in terms of cell numbers and increased ALP or GAG production 
when used as a scaffold for bone19 and cartilage20 tissue engineer-
ing respectively. In an earlier study,38 we demonstrated the in 
vivo bone forming ability of Ca-P coated electrospun scaffolds 
in combination with goat MSCs in a subcutaneous nude mouse 
model and hence decided to add another layer of functionality 
to the scaffolds by coating them with Ca-P, thereby providing 
chemical cues for differentiation. By using biomimetic method 
based on immersion in an aqueous solution of inorganic salts at 
near-physiological conditions, we succeeded in homogenously 
coating both 3DF and 3DF + ESP scaffolds with a layer of Ca-P, 
that was a mixture of OCP and CA, which are considered precur-
sor and end phase of mineral part of bone24,39,40 respectively.
All scaffolds allowed the adhesion and proliferation of hMSCs, 
and at 21 d, ECM production was observed inside the scaffolds. 
No effect of either ESP mesh or Ca-P coating was found on cell 
proliferation; however, cell number at 21 d, expressed in terms of 
total DNA amount, was lower in coated scaffolds containing ESP 
mesh than in coated 3DF scaffolds. Similarly, in mineralization 
medium, uncoated 3DF + ESP scaffolds had the highest amount 
of DNA after 21 d and this amount was significantly higher than 
that observed in the Ca-P coated 3DF + ESP scaffolds. A pos-
sible reason for a significant decrease in DNA amounts in pres-
ence of electrospun fibers in the coated scaffolds could be that, 
after coating, the pore size of the electrospun meshes decreases 
to a size whereby the cells are trapped in the first electrospun 
layer at the periphery of the scaffold and therefore do not opti-
mally use the whole scaffold for proliferation. Although in this 
a significantly lower expression of ON compared with 3DF+ESP 
scaffolds.
On day 21, significant upregulation of BMP-2 and OP was 
again observed in 3DF coated (basic and mineralization medium) 
and 3DF + ESP coated (basic medium) scaffolds. OP expression 
showed nearly 40 and 70 fold induction in coated scaffolds with 
and without electrospun fibers respectively. Significant downreg-
ulation of BSP and ALP expression due to the presence of coating 
was observed for both sets of coated scaffolds in basic medium.
Effect of electrospun fibers. On day 7, the presence of electros-
pun fibers led to a significant downregulation in the expression 
of BSP, ALP and OC in mineralization medium while no sig-
nificant differences in gene expression of osteogenic markers was 
observed in the basic medium. On day 21, statistically significant 
differences in gene expression were observed only for BMP-2 and 
OP in basic medium. In the presence of Ca-P coating, a positive 
effect of the electrospun mesh was observed in the case of BMP-2 
whereas the addition of an electrospun mesh led to a significantly 
lower expression of OP. No differences due to the presence of an 
electrospun mesh were observed in mineralization medium.
Discussion
RP in the form of 3DF deposition was combined with ESP and 
Ca-P coatings to successfully fabricate hybrid scaffolds for use in 
bone tissue engineering. Although 3DF and ESP based scaffolds 
have been separately used for tissue engineering applications, we 
hypothesized that a combination or merger of these two tech-
nologies would lead to improved scaffold properties at different 
scales. While 3DF scaffolds can provide the necessary mechani-
cal stability6,37 and support in compression, the ESP scaffolds 
Figure 4. Metabolic activity of cells seeded on different scaffolds in basic and mineralization medium on days 7 and 21 measured using Alamar Blue 
assay. Data are represented as mean ± standard deviation.
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cell retention without closure of pores due to the coating in vitro. 
It should however be emphasized that in vivo, optimal conditions 
can be different, given the fact that in vivo, degradation behavior 
of both polymeric mesh and Ca-P coatings is different too and 
that additional needs of nutrient supply, blood vessel ingrowth 
etc. need to be met as well.
The effect of Ca-P coating on cell proliferation depends on 
many factors like Ca-P phase, crystallinity and therewith related 
degradation behavior of the coating.43-46 We previously reported 
a decrease in DNA amounts in hMSCs on electrospun fibers 
coated with a Ca-P layer similar to the one used in the present 
study as compared with the uncoated fibers,41 which is in accor-
dance with the results obtained here with hybrid 3DF+ESP scaf-
folds. Different apatite structures47 seeded with MC3T3-E1 cells 
showed lower cell number compared with tissue culture plastic 
after different time points (4 and 14 d) and Anselme and cowork-
ers43 showed that proliferation of human bone derived cells on 
plasma sprayed hydroxyapatite (HA) coatings was only pos-
sible after prolonged soaking of the coated scaffolds in culture 
medium. In contrast, PLLA films coated with apatite or collagen/
apatite blend showed a significantly higher proliferation of Saos-2 
cells compared with bare PLLA films.48 It is therefore difficult to 
draw general conclusions on the effect of Ca-P on proliferation 
of MSCs. In the present study, however, the effect of Ca-P coat-
ing on cell number was only visible for hybrid scaffolds, and not 
for 3DF ones, which indeed suggests that the “clogging” effect 
caused by physical presence of the Ca-P layer may be of bigger 
importance that the chemical effect of presence of Ca-P or release 
of calcium and phosphate ions.
While in vitro studies on combination of ESP and 3D RP 
scaffolds have been performed,19,20,42 they have mainly assessed 
cell proliferation, morphology and biochemical expression of typ-
ical markers like ALP and GAG on cell lines or animal derived 
cells. In order to assess applicability of these technologies in tis-
sue repair and regeneration, experiments with human cells are 
of importance prior to in vivo testing. Therefore, we seeded our 
scaffolds with bone marrow derived hMSCs and analyzed the 
gene expression of various osteogenic markers at two different 
time points —day 7 and day 21.
The applied Ca-P coating comprises a mixture of OCP and 
CA, biologically relevant phases of Ca-P. The bioactivity of Ca-P 
coatings in a bony environment that is believed to originate in 
degradation of Ca-P is the main reasons for their use in ortho-
pedic and maxillo-facial implants. This degradation leads to an 
increase in local ion concentration in the vicinity of the implant, 
resulting in subsequent precipitation of a bone like carbonated 
apatite on the substrate.49 Previous studies performed on simi-
lar coatings have shown the formation of a carbonated apatitic 
phase two weeks after an OCP coated Ti plate was placed in 
α-MEM49 suggesting that the degradation process starts earlier. 
In the current experimental set up, the released calcium and/or 
phosphate ions plausibly affected differentiation of hMSCs. Tada 
and coworkers observed increased BMP-2 expression50 in dental 
pulp cells due to elevated levels of calcium, which is in accor-
dance with our results using hMSCs. Another study51 showed 
that at calcium concentrations greater than 6 mM, MC3T3E1 
study we did not measure the thickness of the coating, previ-
ous studies41 using electrospun fibers of the same polymer and 
fiber diameter have shown that this type of coating can reach 
a thickness of approximately 15 μm. Considering that the pore 
size between the ESP fibers is about 40 μm, it is indeed possible 
that the coating has “clogged” the mesh. Decreasing the initial 
fiber density by reducing the spinning time is a way of obtaining 
a less dense ESP mesh, which, in this case, would improve inter-
connectivity of pores throughout the scaffold, thus even through 
the ESP mesh. Hence, in this study, the hypothesized in vitro 
benefit of the entrapment of cells inside the ESP mesh was not 
directly visible, particularly when the scaffolds were coated with 
Ca-P. In previous studies where RP and ESP technologies were 
integrated19,20 to study the behavior of SaOS-2 osteosarcoma cell 
line and bovine chondrocytes respectively, a higher ratio of elec-
trospun to RP layers (1 ESP layer per 2 RP layers) was used than 
in the current study (1 ESP layer every 4 RP layers). In these 
studies, cell proliferation was positively influenced by the pres-
ence of ESP fibers at early time points, however, in the study by 
Moroni et al., a decrease in DNA amounts at later time points 
was observed, which was explained by the initiation of chondro-
genic differentiation of cells. Cell differentiation as a cause of 
a decrease in cell proliferation was not observed in the present 
study. Another study that combined RP and ESP showed sig-
nificant differences in porcine chondrocyte proliferation up to 4 
d due to the presence of the electrospun mesh but no difference 
after 7 d, which was attributed to saturation in cell proliferation 
within the scaffold.42 These results suggest that an increase in the 
number of ESP layers and a decrease of their density as compared 
with the conditions used in our study should ensure significant 
Figure 5. Amount of DNA after 21 d on different scaffolds in basic and 
mineralization medium as measured using CyQuant assay. Data are 
represented as mean ± standard deviation. *Statistically significant dif-
ferences (p < 0.05).
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osteogenesis and overexpression of Ang-1 led to enhanced ALP 
activity, OC production and mineralization.52 Calcium concentra-
tion could play a role in osteogenic differentiation and reproduc-
ing hematopoetic stem cell niche or bone marrow by controlling 
the expression of angiopoietin related genes. Our recent results 
osteoblasts showed enhanced mineralization and expression of 
angiopoietin-1 (Ang-1) that promotes the structural integrity of 
blood vessels and variation in expression of angiopoietin-2 (Ang-
2), a naturally occurring antagonist for promoting blood vessel 
growth. Besides angiogenic activity, Ang-1 is also involved in 
Figure 6. Cell morphology on scaffolds after 21 d. (A–D) represent 3DF (uncoated and coated) and 3DF + eSp (uncoated and coated scaffolds) in basic 
medium. Inset in C shows hMSCs on the electrospun layer (indicated by white arrow). (E) Higher magnification image of hMSCs attaching calcium-
phosphate coatings. White arrow indicates coating. (F) Higher magnification image of hMSCs on electrospun fibers (white arrow). Scale bars A-D = 200 
μm. Inset in C = 500 μm, E and F = 50 μm.
e23705-8 Biomatter Volume 3 Issue 1
Figure 7. qpCR analysis for osteogenic panel of genes after 7 d in culture. * represents p < 0.05. Data are represented as mean ± standard deviation.
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Figure 8. qpCR analysis for osteogenic panel of genes after 21 d in culture. * represents p < 0.05. Data are represented as mean ± standard deviation.
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KD Scientific). The other end of the syringe was connected to 
a needle, on which a positive high voltage was applied using a 
high voltage generator (Gamma High Voltage Research Inc.). A 
metallic sheet of stainless steel was the collector (ground). An 
electrostatic field was formed between the needle and the collec-
tor when the generator was turned on. The polymer solution was 
pushed through the syringe to the tip of the needle. When the 
electrostatic field strength overcame the surface tension of the 
liquid drop at the tip of the needle, the drop was stretched into 
fibers and deposited onto the 3DF scaffold placed on the collec-
tor. A flow rate of 15 mL/h, distance of 15 cm and voltage of 12 
kV were used for the spinning and fibers were deposited for 30 
sec on the collector. This process was repeated at 0.9 mm, 2.025 
mm and 2.925mm of 3DF scaffold height to create 3DF-ESP 
scaffolds. For the in vitro experiments, configuration 1 ESP layer 
per 4 3DF layers was selected. Temperature and humidity were 
monitored during the process and ranged between 19.6–20.4°C 
and 33–42% respectively.
Preparation of biomimetic Ca-P coatings on scaffolds. 3DF 
and 3DF-ESP scaffolds were punched to cylinders (5 mm diam-
eter, 4 mm height) and coated with Ca-P using a two-step coat-
ing process. In the first step, a five times concentrated simulated 
body fluid solution (SBF × 5) was prepared by dissolving reagent 
grade NaCl (40 g), CaCl
2
.2H
2
O (1.84 g), MgCl
2
.6H
2
O (1.52 
g), NaHCO
3
 (1.76 g) and Na
2
HPO
4
.2H
2
O (0.89 g) salts in 1l 
of demineralised water at 37°C under CO
2
 gas bubbling. The 
CO
2
 source was then removed from the solution and the 3DF 
and 3DF-ESP scaffolds were immersed in the solution in a partly 
open vial and left to coat for 24 h under continuous gentle stir-
ring at 37°C. This process was previously shown to result in a 
formation of thin, amorphous Ca-P layer.
In the second step, scaffolds pre-coated in step 1 were 
immersed in a calcium phosphate solution (CPS) at physiological 
pH of 7.4 and temperature of 37°C for 24 h to deposit a crys-
talline layer onto previously formed amorphous Ca-P layer. CPS 
was prepared by dissolving NaCl (8 g), CaCl
2
.2H
2
O (0.59 g), 
Na
2
HPO
4
.H
2
O (0.36 g) and Tris (6.05 g) in MilliQ water and 
the pH of the solution was adjusted to 7.4 with 1M HCl. The 
coated scaffolds were thoroughly washed in MilliQ water and 
dried overnight at 50°C.
Characterization of scaffolds. The architecture and composi-
tion of the different types of scaffolds were characterized using 
Environmental SEM in secondary electron mode coupled to 
EDX analyzer (XL 30 ESEM-FEG, Philips). FTIR spectroscopy 
(Perkin Elmer Spectrum 1000) was performed on the coatings 
which were obtained by scratching the coated scaffolds. Fiber 
diameters were calculated from SEM micrographs using Image J 
(National Institutes of Health).
HMSC isolation and cell seeding. Bone marrow aspirates were 
obtained after written informed consent, and hMSCs were iso-
lated and proliferated as described previously.59 Briefly, aspirates 
were resuspended by using 20-gauge needles, plated at a density 
of 5 × 105 cells/cm2 and cultured in hMSC proliferation medium 
containing α-minimal essential medium (Life Technologies), 
10% fetal bovine serum (Cambrex), 0.2 mM ascorbic acid (Asap; 
Life Technologies), 2 mM L-glutamine (Life Technologies), 100 
also showed a 3-fold increase in BMP-2 levels in hMSCs after 6 
h of culture with 7.8 mM calcium.53 Besides BMP-2, the gene the 
expression of which was consistently upregulated in coated scaf-
folds was OP. The high levels of expression (~40 and 70 fold) are 
comparable to earlier studies performed on ceramics54 where OP 
expression showed a 200,000 fold increase in tricalcium phos-
phate ceramics compared with cultures on tissue culture plastic. 
Beck et al.55 showed that phosphate is a specific signal for induc-
ing OP expression and further elucidated possible signaling path-
ways for the regulation of OP.56 Other osteogenic markers like 
cbfa1, a transcription factor linked to osteoblast proliferation and 
differentiation and a master switch in the osteogenic differentia-
tion of mesenchymal stromal cells57 was also upregulated on day 
7 in coated scaffolds. Arafat et al.32 also observed the same trend 
in cbfa1 expression in porcine MSCs on rapid prototyped PCL-
TCP scaffolds coated with carbonated HA on days 17 and 24.
It is interesting to note that most of the observed upregulation 
of genes due to scaffold modifications (predominantly presence 
of Ca-P) occurred in basic medium as opposed to the mineraliza-
tion medium. While this facet needs further investigation, it sug-
gests that standard culturing protocols for 2D cell cultures may 
not yield the same results when other cues like Ca-P coatings are 
incorporated into scaffolds.
Materials and Methods
Materials. PolyActive™ (PA) was provided by PolyVation BV, 
The Netherlands. Following an aPEOTbPBTc nomenclature, the 
composition used in this study was 300PEOT55PBT45 where, 
(1) is the molecular weight in g/mol of the starting poly(ethylene 
glycol) (PEG) blocks used in the copolymerisation, while (2) and 
(3) are the weight ratios of the PEOT and PBT blocks, respec-
tively. All the salts and reagents used for the preparation of the 
coating were purchased at either Merck or Sigma-Aldrich.
Fabrication of 3DF scaffolds. 3D scaffolds were fabricated 
by 3DF using a Bioplotter. The Bioplotter (Envisiontec GmbH, 
Germany) is an XYZ plotter device as previously described.58 
Briefly, polymer granules were loaded onto a stainless steel syringe 
and heated at 195°C using a thermostat controlled cartridge unit, 
fixed on the “X”-mobile arm of the apparatus. A pressure of 4 
bars (nitrogen) was applied to the syringe through a pressurised 
cap once the polymer had melted. Rectangular block models 
were loaded on the Bioplotter CAM (PrimCAM) software and 
deposited layer by layer as the polymer was extruded through a 
nozzle (0.7mm OD) on a stage. The deposition speed was varied 
between 200–300 mm/min. The spacing between fibers in the 
same layer was set at 0.8 mm and the layer thickness was 0.225 
mm. A 0–90° configuration was used for scaffold architecture 
where fibers were deposited with 90° orientation steps between 
successive layers.
Deposition of electrospun fibers onto 3DF scaffolds. PA 
was dissolved in a mixture of chloroform- hexafluoroisopropa-
nol (HFIP) (78–22%v/v) respectively. A 28% (w/v) PEOT/PBT 
solution in chloroform- HFIP were prepared and stirred overnight 
at room temperature. The solution was loaded into a syringe and 
the flow rate was controlled using a syringe pump (KDS 100, 
www.landesbioscience.com Biomatter e23705-11
RNA Isolation and gene expression analysis using 
Quantitative PCR. To analyze the expression of osteogenic 
markers by hMSCs, total RNA was isolated using a combination 
of the TRIzol® method with the NucleoSpin®RNA II isolation 
kit (Macherey-Nagel). Briefly, scaffolds were washed with PBS 
once and 1ml of TRIzol reagent (Invitrogen) was added to the 
samples. After one freeze/thaw cylcle, chloroform was added, fol-
lowed by phase separation by centrifugation, the aqueous phase 
containing the RNA was collected, mixed with equal volume 
of 75% ethanol and loaded onto the RNA binding column of 
the kit. Subsequent steps were in accordance with the manufac-
turer’s protocol. RNA was collected in RNase-free water. The 
quality and quantity of RNA was analyzed by gel electrophoresis 
and spectrophotometry. Three hundred ng of RNA were used 
for first strand cDNA synthesis using iScript (Bio-Rad) accord-
ing to the manufacturer’s protocol. One microliter of undiluted 
cDNA was used for subsequent analysis. PCR was performed on 
a Light Cycler real time PCR machine (Roche) using SYBR green 
I master mix (Invitrogen). Data was analyzed using Light Cycler 
software version 3.5.3, using the fit point method by setting the 
noise band to the exponential phase of the reaction to exclude 
background fluorescence. Expression of osteogenic marker genes 
was normalized to GAPDH (5'-CGC TCT CTG CTC CTC 
CTG TT- 3' and 5'-CCA TGG TGT CTG AGC GAT GT-3') 
levels and fold inductions were calculated using the comparative 
ΔCT method.27 The following primer sequences were used for 
the osteogenic marker genes: Osteocalcin (OC) (5'-GGC AGC 
GAG GTA GTG AAG AG-3' and 5'-GAT GTG GTC AGC 
CAA CTC GT-3'), Bone Sialoprotein (BSP) (5'-TGC CTT GAG 
CCT GCT TCC-3' and 5'-CAA AAT TAA AGC AGT CTT 
CAT TTT G-3'), Runt-related Transcription Factor-2 (RUNX2/
cbfa-1) (5'-GGA GTG GAC GAG GCA AGA GTT T-3' and 
5'-AGC TTC TGT CTG TGC CTT CTG G-3'), Collagen 
type 1 (5'-AGG GCC AAG ACG AAG ACA TC-3' and 5'- AGA 
TCA CGT CAT CGC ACA ACA-3'), Osteopontin (OP) (5'-
CCA AGT AAG TCC AAC GAA AG-3' and 5'-GGT GAT 
GTC CTC GTC TGT A-3'), Osteonectin (ON) (5'-ACT GGC 
TCA AGA ACG TCC TG-3' and 5'-GAG AGA ATC CGG TAC 
TGT GG-3'), and Alkaline Phosphatase (ALP) (5'-GAC CCT 
TGA CCC CCA CAA T-3' and 5'-GCT CGT ACT GCA TGT 
CCC CT-3'). For amplification of Bone Morphogenetic Protein-2 
(BMP-2), a gene-specific primer mix was used (SA Biosciences), 
according to the manufacturer’s protocol.
Statistical analysis. One way ANOVA with Tukey’s multiple 
comparison post-hoc test was performed. The level of signifi-
cance was set at 0.05. All data presented are expressed as mean ± 
standard deviation. Only significant differences due to the effect 
of coating and presence of electrospun fibers have been shown.
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units/ml penicillin (Life Technologies), 10 μg/ml streptomycin 
(Life Technologies), and 1 ng/ml basic fibroblast growth factor 
(FGF) (Instruchemie). Cells were grown at 37°C in a humid 
atmosphere with 5% CO
2
. Medium was refreshed twice a week, 
and cells were used for further sub-culturing or cryopreservation. 
The hMSC basic medium was composed of hMSC proliferation 
medium without basic FGF. Mineralization medium was com-
posed of hMSC basic medium with supplemented with 10-8 M 
dexamethasone (Sigma) and 0.01 M β-glycerophosphate (BGP; 
Sigma). Cells were trypsinised prior to seeding on scaffolds.
The in vitro experiments were performed with cells from one 
donor at passage 3. Cylinders (5mm diameter, 4mm height) of 
the four types of scaffolds (3DF, 3DF + coating, 3DF + ESP 
and 3DF + ESP + coating) were soaked in 70% ethanol for 30 
min and dried overnight in a laminar flow cabinet. The scaf-
folds were washed twice with sterile PBS, transferred to a 25 well 
non-treated polystyrene plate (Greiner Bio One) and incubated 
at 37°C in a humid atmosphere with 5% CO
2
 for four hours 
in basic cell culture medium. After removing the medium, each 
scaffold was seeded with 700,000 cells approximately for PCR 
analysis and 500,000 cells for Alamar blue and DNA assay in 80 
μl basic medium. The cell-scaffold constructs were incubated for 
three hours to allow cell attachment and topped up to 2 ml with 
appropriate media. Scaffolds were cultured either in basic media 
or mineralization media and medium was refreshed twice a week. 
As a control, T- 25 flasks were seeded at 5,000 cells/cm2 in basic 
and mineralization medium.
Alamar blue assay for cell metabolism. Metabolism was 
assessed using Alamar blue assay according to the manufacturer’s 
protocol. Briefly, culture medium was replaced with medium con-
taining 10% (v/v) Alamar blue solution (Biosource) and the cells 
were incubated at 37°C for 4 h. Fluorescence was measured at 
590 nm on a Perkin Elmer Victor3 1420 Multilabel plate reader. 
Proliferation was analyzed on day 7 and 21 and the readout from 
the scaffolds was corrected with the blank from each group and 
normalized to scaffold weight.
DNA assay. Scaffolds were washed with PBS and frozen at 
-80°C overnight. The constructs were then digested at 56°C in 
a Tris-EDTA buffered solution containing 1 mg/ml proteinase 
K, 18.5 μg/ml pepstatin A and 1 μg/ml iodoacetamide (Sigma-
Aldrich) for 18 h. Cell numbers were determined using the 
CyQUANT® DNA quantification kit (Invitrogen) with 50 μl of 
cell lysate according to the manufacturer’s protocol. Fluorescence 
at an excitation wavelength of 480 nm and an emission wave-
length of 520 nm was measured using a Perkin Elmer Victor3 
1420 Multilabel plate reader and total amount of DNA was nor-
malized to scaffold weight.
Cell morphology using SEM. On day 21, one sample from 
each group was used for SEM analysis. The medium was removed 
and the scaffolds were washed twice with PBS and fixed in 10% 
formalin for one hour. After rinsing with PBS, the scaffolds were 
dehydrated in a series of increasing ethanol concentrations (70%, 
80%, 90%, 96%, 100% × 2), 15 min in each concentration, 
before being dried in a critical point dryer (Balzers CPD-030). 
The samples were then sputter coated with gold (Cressington) for 
observation on the SEM.
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